WO2000033246A1 - Procede et systeme d'identification de produits medicaux - Google Patents

Procede et systeme d'identification de produits medicaux Download PDF

Info

Publication number
WO2000033246A1
WO2000033246A1 PCT/US1999/028095 US9928095W WO0033246A1 WO 2000033246 A1 WO2000033246 A1 WO 2000033246A1 US 9928095 W US9928095 W US 9928095W WO 0033246 A1 WO0033246 A1 WO 0033246A1
Authority
WO
WIPO (PCT)
Prior art keywords
transponder
memory
pill
signal
power
Prior art date
Application number
PCT/US1999/028095
Other languages
English (en)
Inventor
Akira Ishikawa
Nabuo Takeda
Suzanne I. Ahn
Samuel S. Ahn
Steven R. Hays
F. Andrew Gaffney
Original Assignee
Ball Semiconductor, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ball Semiconductor, Inc. filed Critical Ball Semiconductor, Inc.
Priority to AU18328/00A priority Critical patent/AU1832800A/en
Publication of WO2000033246A1 publication Critical patent/WO2000033246A1/fr

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
    • G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
    • G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
    • G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
    • G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
    • G06K19/077—Constructional details, e.g. mounting of circuits in the carrier
    • G06K19/07749—Constructional details, e.g. mounting of circuits in the carrier the record carrier being capable of non-contact communication, e.g. constructional details of the antenna of a non-contact smart card
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06K—GRAPHICAL DATA READING; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS
    • G06K19/00—Record carriers for use with machines and with at least a part designed to carry digital markings
    • G06K19/06—Record carriers for use with machines and with at least a part designed to carry digital markings characterised by the kind of the digital marking, e.g. shape, nature, code
    • G06K19/067—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components
    • G06K19/07—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips
    • G06K19/0723—Record carriers with conductive marks, printed circuits or semiconductor circuit elements, e.g. credit or identity cards also with resonating or responding marks without active components with integrated circuit chips the record carrier comprising an arrangement for non-contact communication, e.g. wireless communication circuits on transponder cards, non-contact smart cards or RFIDs
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
    • H01L2924/10—Details of semiconductor or other solid state devices to be connected
    • H01L2924/1015—Shape
    • H01L2924/1017—Shape being a sphere

Definitions

  • This invention is related generally to the field of medical product inventory and control, and more particularly to a method of and system for identifying, inventorying, and locating medical products, such as pills, surgical sponges and instruments, and the like.
  • BIOMEDICAL IC BIOMEDICAL IC
  • the existing common inventory system for medical practices does not allow for the identifying tags to be biocompatible for use in the body.
  • There is a need to accurately identify, locate, and control medical products comprising medication, surgical sponges and instruments.
  • the need stems from patient safety and health care provider liability concerns, as well as from cost concerns.
  • the present invention disclosed and claimed herein in one aspect thereof, comprises a method of tagging a medical product with an attached or imbedded externally powered transponder.
  • the medical product may be a pill, a sponge, a surgical instrument, or any other medical item.
  • the transponder includes a non-volatile memory that contains identifying data for the medical item.
  • the item is identified by reading the memory externally of the item to obtain the identifying data.
  • the memory is read by generating electromagnetic radiation externally of the item to power the transponder.
  • a radio frequency (RF) signal is modulate with the identifying data, and the modulated RF signal of the item is received externally.
  • RF radio frequency
  • FIGURE 1 illustrates a general block diagram of a tag/monitoring system according to a disclosed embodiment
  • FIGURE 2 illustrates a more detailed block diagram of disclosed system
  • FIGURE 3 illustrates a sectional view of a transponder, preferably comprising a spherical-shaped semiconductor device on which an integrated circuit has been formed
  • FIGURE 4 illustrates an alternative embodiment having a pair of interconnected spherical ball devices forming the transponder
  • FIGURE 5 illustrates a cross section view of the interface contacts along the line 5-5 of FIGURE 4 of a circuit ball
  • FIGURE 6 illustrates a detailed block diagram of an alternative embodiment of the transponder/monitoring system, according to the disclosed architecture
  • FIGURE 7 illustrates a schematic block diagram of the monitor and the transponder/monitoring system, according to a disclosed embodiment
  • FIGURES 8A-8C illustrate alternate embodiments for the transmit/receive operation
  • FIGURE 9 illustrates a side view of an alternative embodiment utilizing additional circuitry or structure attached to a transponder for providing a local power source
  • FIGURE 10 illustrates a schematic block diagram of a transponder having a battery as the local power supply system
  • FIGURE 11 illustrates a perspective view of a transponder, wherein the inductive element is depicted as strips of conductive material wrapped around the outer region of the transponder;
  • FIGURE 12 illustrates a cross-sectional diagram of the semiconductor surface of a transponder having the conductive strips which an inductive element.
  • a system 11 includes a pill 13 having a substantially microscopic externally-powered transponder 15 embedded therein.
  • the pill 13 is any of several well-known types of oral medication in pill form.
  • transponder 15 includes a memory containing identifying data for the pill.
  • the identifying data may comprise any combination of the following information; the identification of the medication, the dosage of the medication contained in the pill, the identity of the manufacturer of the pill, the date of manufacture of the pill, a unique serial number for the pill, and personal information of the customer to whom the pill was sold, such as name and address.
  • monitoring unit 17 may be a handheld device or it may be a fixed device in a hospital, doctor's office, pharmacy, or other facility. As will be explained in detail hereinafter, monitoring unit 17 provides power to and interrogates transponder 15, and displays or records the data read from transponder 15. Monitoring unit 17 can be used to obtain identifying information for pill 15 outside of a body or inside the body after pill 13 has been ingested. Additionally, monitoring unit 17 can obtain identifying information from transponder 15 after pill 13 has dissolved in the body, which is particularly useful in overdose situations.
  • the ball can also be fabricated to incorporate one or more sensors that individually or in combination detect, for example, moisture or change in pH to determine whether the pill has dissolved and exposed the ball to the environment of the gut.
  • the transponder 15 is a passive transponder preferably of the type disclosed (only from a functional standpoint) generally in several patents: Carroll et al., U.S. Patent No.
  • Monitoring unit 17 includes a power generatorl9.
  • the power generator 19 directs low frequency electromagnetic radiation at transponder 15.
  • the low frequency electromagnetic radiation generated by the power generator 19 induces a current in a power coil 21 carried by transponder 15.
  • a power regulator 23 rectifies and regulates the current induced in power coil 21 to provide a relatively constant DC voltage level of about three volts to the circuitry of transponder 15.
  • Transponder 15 includes a memory indicated generally at 25.
  • Memory 25 is preferably an electrical erasable programmable read only memory (EEPROM) of the type well known in the art.
  • EEPROM electrical erasable programmable read only memory
  • memory 25 includes a programmable memory array, address decoders, and appropriate output buffers, all of which is well known to those skilled in the art.
  • Memory 25 also includes clocking and sequencing circuitry for outputting the data stored therein.
  • Memory 25 is programmed with identifying data for the pill. Typically, the identifying data is programmed into memory 25 by the manufacturer of the pill. This identifying information can include the identity of the drug or medication of the pill and the dosage level of the pill.
  • the data may also include such information as lot number, date of manufacture, location of manufacture, or any other information the manufacturer may desire or be required to include in memory 25, such as a unique serial number so that each pill can be separately identified even from identical pills of the same lot.
  • the size of memory 25 is large enough to contain the data.
  • Transponder 15 includes on-board data communication circuits, which is essentially the modulation site of a modem.
  • the output from memory 25 is coupled to the input of a voltage controlled oscillator (VCO) 27.
  • VCO 27 produces a signal the frequency of which is related to the input voltage.
  • the output for memory 25 is either a high voltage level or a low voltage level.
  • VCO 27 applies frequency-shift keying (FSK) to the data received from memory 25.
  • FSK frequency-shift keying
  • PSK phase-shift keying
  • QAM quadrature amplitude modulation
  • the FSK signal produced by VCO 27 modulates an RF signal produced by an RF oscillator 29.
  • the modulation occurs in a mixing circuit 31.
  • the modulated output from mixing circuit 31 is output to a radio frequency amplifier 33.
  • Amplifier 33 amplifies the signal and outputs the amplified signal to an antenna 35.
  • Antenna 35 may be a separate antenna carried by transponder 15, or it may be power coil 21.
  • Antenna 35 of transponder 15 radiates the data modulated RF signal exterior of transponder 15.
  • the data-modulated RF signal is received by a radio frequency receiver 37, which is part of monitoring station 17.
  • Radio frequency receiver 37 is a conventional receiver and it preferably includes an on-board modem for demodulating the signal.
  • Radio frequency receiver 37 is coupled to a CPU 39, which decodes the data received from transponder 15.
  • Monitoring unit 17 includes a display 41 connected to CPU 39.
  • Display 41 may be a simple LED display. Alternatively, display 41 may be a video monitor with elaborate graphical features.
  • FIGURE 3 there is illustrated a coss section of a transponder, preferably comprising a spherical-shaped semiconductor device on which an integrated circuit has been formed.
  • a spherical-shaped integrated circuit semiconductor device (sometimes referred to herein as a "ball") is described in, commonly assigned, U.S. Patent No. 5,955.776, filed May 16, 1997, issued September 21,1999, and entitled "Spherical Shaped Semiconductor Integrated Circuit,” the disclosure of which is incorporated herein by reference.
  • Transponder 15 is built on a substantially spherical semiconductor substrate 43, which may be doped P-type or N- type in accordance with the particular requirements of the fabrication process.
  • Semiconductor circuitry indicated generally at 45 resides on substrate 43.
  • Circuitry 45 includes the elements illustrated in FIGURE 2, including power regulator 23, memory 25, voltage controlled oscillator 27, RF oscillator 29, mixing circuit 31, and amplifier 33, as well as other circuitry.
  • Substrate 43 and circuitry 45 are covered with an insulating layer 47.
  • Insulating layer 47 is preferably formed of silicon dioxide or phosphosilicate glass.
  • a power coil 21, described with respect to FIGURE 2 is formed of helically wrapped windings over the insulating shell 47.
  • Power coil 21 may be fabricated from a deposited layer of aluminum that is patterned and etched using conventional semiconductor fabrication techniques. The actual number of individual windings of power coil
  • Transponder 15 is coated with or encapsulated in a coating layer 49 of a biological inert material such as phosphosilicate glass. Coating 49 can withstand the acidity of the stomach to a very low pH level and it is not subject to the enzymatic actions of the digestive tract. Additionally, coating 49 is inert to and does not react with the material of the pill 13. Transponder 15 is substantially spherical and preferably about one millimeter in diameter. The very small size of transponder 15 enables it to be embedded in a pill 13 without increasing substantially the overall volume of the pill. However, the device should be made large enough not to be absorbed through the microvilli in the lining of the digestive tract.
  • a biological inert material such as phosphosilicate glass.
  • the transponder 51 comprises two individual balls interconnected by metal contacts or solder bumps 53.
  • the balls of transponder 51 include a circuit ball 55 and a memory ball 57.
  • Balls 55 and 57 are constructed in the manner illustrated with respect to FIGURE 3.
  • the sensor ball 55 includes a substantially spherical semiconductor substrate upon which resides the power coil 21, power regulator 23, voltage controlled oscillator 27, RF oscillator 29, mixing circuit 31, and amplifier 33 of FIGURE 2.
  • the memory ball 57 includes a substantially spherical semiconductor substrate upon which resides memory 25 of FIGURE 2. By clustering one or more of the memory balls 57 with the circuit ball 55, the size of memory available to transponder 51 may be increased greatly.
  • Transponder 51 is encapsulated in a biologically inert material such as phosphosilicate glass.
  • FIGURE 5 there is illustrated a cross section view of the interface contacts along the line 5-5 of FIGURE 4 of a circuit ball.
  • the contacts 53a and 53b may be power contacts, such as a positive 3.0 volts and ground, which can be passed from the circuit ball 55 to the memory ball 57 by conductors on its surface using two of a group of similar contacts (designated collectively by numeral 53 in FIGURE 4).
  • the contacts 53c and 53d may be data and control contacts for communications between the circuit ball 55 and memory ball 57. Note that this embodiment is not limited to two interconnected balls, but may comprise any number of balls interconnected to provide the desired function.
  • a monitoring unit 61 includes an antenna/coil 63 that transmits RF power to an antenna coil 65 of a ball transponder 67. Power is transported either by RF radiation or by magnetic coupling between antenna coil 63 and antenna coil 65. Monitoring unit 61 generates RF power with an RF oscillator 69 coupled to an RF amplifier 71. The RF amplifier 71 is coupled to antenna/coil 63. The RF power received at antenna/coil 65 of transponder 67 is rectified and smoothed by an RF rectifier smoother 73 coupled to antenna/coil 65.
  • RF rectifier smoother 73 converts radio frequency energy to a DC voltage.
  • DC power is stored in a DC power storage unit 75, which preferably includes a capacitor.
  • the capacitor of DC power storage unit 75 may be included in the smoothing portion of the RF rectifier smoother 73.
  • a voltage regulator 77 is coupled to DC power storage unit 75. Voltage regulator 77 makes the DC voltage powering transponder 67 stable for any condition or distance between monitoring unit 61 and transponder 67. Voltage regulator 77 supplies DC voltage to all circuits of transponder 67 in a manner well known to those skilled in the art.
  • Transponder 67 includes a non-volatile memory 79, which is programmed with identifying information. The output from memory 79 is converted to a frequency signal by a converter 81.
  • Control logic 83 controls converter 81. Control logic 83 may control the activity of all the circuits on transponder 67, though only a connection to converter 81 is shown in FIGURE 6. Control logic 83 may be a
  • transponder 67 includes an RF oscillator 85.
  • the frequency of RF oscillator 85 is preferably not the same as the frequency generated by RF oscillator 69 of control unit 61.
  • the RF signal produced by RF oscillator 85 is modulated with the signal produced by converter 81 in an RF modulator 87.
  • the modulated RF signal is amplified by an RF amplifier 89, which is coupled to antenna/coil 65.
  • Transponder 67 may operate under AM, FM, PM, or other analog or digital modulation methods.
  • the information transmitted from transponder 67 is received at antenna coil 63 of monitoring unit 61.
  • the RF signal received at antenna/coil 63 is detected by an RF detector 91 and amplified by an RF amplifier 93.
  • the amplified RF signal is converted to a digital signal by a converter 95, which is an A/D (analog- to-digital) converter or a demodulator.
  • Converter 95 is coupled to control logic 97, which processes the data received from transponder 67, and controls a display 99 and other electrical circuitry of monitoring unit 61.
  • Display 99 is either a display to a human operator or it may be an interface to other equipment.
  • FIGURE 7 there is illustrated a more detailed schematic block diagram of the monitor and the transponder/monitoring system, according to a disclosed embodiment.
  • the transponder 67 as described hereinabove, is operable to provide unique information according to its programmed instructions.
  • the illustrated embodiment of FIGURE 7 is that associated with a "passive" system, which term refers to a system having no battery associated therewith.
  • an inductive coupling element 704 in the form of an inductor, which is operable to pick up an alternating wave or impulse via inductive coupling, and extract the energy therein for storage in the inductive element 704. This will create a voltage across the inductive element 704 between a node 706 and a node 708.
  • a diode 710 is connected between the node 708 and the node 712, with the anode of diode 710 connected to node 708 and the cathode of diode 710 connected to a node 712.
  • the diode 710 will be fabricated as a Schottky diode, but can be a simple PN semiconductor diode.
  • the PN diode will be described, although it should be understood that a Schottky diode could easily be fabricated to replace this diode.
  • the reason for utilizing a Schottky diode is that the Schottky diode has a lower voltage drop in the forward conducting direction.
  • the diode 710 is operable to rectify the voltage across the inductive element 704 onto the node 712, which has a capacitor 714 disposed between node 712 and node 706.
  • Node 712 is also connected through a diode 716 having the anode thereof connected to node 712 and the cathode thereof connected to a node 718 to charge up a capacitor 720 disposed between node 718 and
  • the capacitor 720 is the power supply capacitor for providing power to the transponder 67.
  • the capacitor 714 as will be described hereinbelow, is operable to be discharged during operation of the system and, therefore, a separate capacitor, the capacitor 720, is required for storing power to power the system of the transponder 67.
  • a CPU 738 is provided to control and process on-board functions of the transponder 67.
  • a clock circuit 740 provides timing to the system.
  • a memory 739 is provided in communication with the CPU 738 to allow the CPU 738 to store data therein for later transmittal back to the remote location or for even storing received instructions.
  • This memory 739 can be volatile or it can be non-volatile, such as a ROM, and can be used to store unique information according to its programmed function. For the volatile configuration, of course, this will lose all information when the power is removed.
  • the memory 739 is also connected to an A/D converter 736 for conversion of the memory data prior to transmission to the monitoring station 61, or the memory data may be pulled from the memory 739 by the CPU 738 for conversion to the A D converter 736.
  • SYSTEM PWR output node System power to all power-consuming elements of the monitor 10 is provided at the SYSTEM PWR output node.
  • a receive/transmit circuit 742 is provided for interfacing to node 712 through a resistive element 744. This allows RF energy to be transmitted to node 712. It is important to note that the semiconductor junction across diode 710 is a capacitive junction. Therefore, this will allow coupling from node 712 to node 708. Although not illustrated, this could actually be a tuned circuit, by selecting the value of the capacitance inherent in the design of the diode 710.
  • this allows an RF connection to be provided across diode 710 while allowing sufficient energy to be input across conductive element 704 to provide a voltage thereacross for rectification by the diode 710 and capacitor 714.
  • the frequency of this connection will be in the MHz range, depending upon the design.
  • the remote monitor system 61 which is disposed outside of the body and proximate to the transponder 67 includes an inductive element 750 which is operable to be disposed in an area proximate to the skin, yet exterior to the body, in the proximity of the transponder 67.
  • the inductive element 750 is driven by a driving circuit 752 which provides a differential output that is driven by an oscillator 754. This will be at a predetermined frequency and power level necessary to couple energy from inductive element 750 to inductive element 704. Since this is an external system, the power of the oscillator can be set to a level to account for any losses through the body tissues.
  • a modulation circuit 756 is provided which is modulated by a transmitter signal in a block 758 that allows information to be modulated onto the oscillator signal of the oscillator 754, which oscillator signal is essentially a "carrier" signal.
  • the information that is transmitted to the transponder 67 could merely be date information, whereas the CPU 738 could operate independent of any transmitted information to provide the correct timing for the output pulses and the correct waveshape therefor.
  • entire control of the system could be provided by the transmit signal 758 and the information carried thereon, since power must be delivered to the illustrated embodiment due to the lack of any independent power in the transponder 67.
  • the information When the information is received from the transponder 67, it is superimposed upon the oscillator signal driving the inductive element 750. This is extracted therefrom via a detector 760 which has the output thereof input to a first low pass filter 762, and then to a second low pass filter 764.
  • the output of low pass filters 762 and 764 are compared using a comparator 766 to provide the data.
  • the filter 762 provides an average voltage output, whereas the filter 764 provides the actual digital voltage output.
  • the output of the comparator 766 is then input to a CPU 770 which also is powered by the oscillator 754 to process the data received therefrom. This can then be input to a display 772.
  • FIGURE 8 A there is provided an oscillator 800 which drives an external inductive element 802.
  • load 804 disposed across the inductive element 802. This is the primary power that is provided to the system.
  • a separate inductive element 806 is provided on the transponder 67, for being inductively coupled to the inductive element 802.
  • a voltage is generated across the inductive element 806, the inductive element 806 being connected between nodes 808 and 810.
  • a diode 812 is connected between node 808 and a power node 814, and a power supply capacitor 816 is disposed across node 814 and a node 810. This allows the voltage on node 808 to be rectified with diode 812.
  • the receive operation in this alternative embodiment, utilizes a separate inductive element or antenna 824 in the transponder 67, which is operable to be connected between nodes 809 and 811.
  • Node 809 is capacitively coupled to a transmit node 830 with a capacitor 832, the capacitor 832 being a coupling capacitor.
  • a transmitter 834 is provided for transmitting received data from a line 836 to the node 830, which is then coupled to the node 809 to impress the RF signal across the inductive element 824.
  • a corresponding inductive element 840 is disposed on the external remote controller of remote monitoring location 61 , which inductive element 840 is operable to be disposed proximate to the inductive element 824, but external to the human body.
  • the inductive element 840 is basically a "pick-up" element which is operable to receive information and function as an antenna, and provide the received signal to a receiver 842.
  • the structure of FIGURE 8B is a separate structure, such that node 809 is isolated from node 808, the power receiving node.
  • any harmonics of the oscillator 800 would, of course, leak over into the inductive element 824. This can be tuned out with the use of some type of tuning element 844 on the transponder 67 disposed across inductive element 824, and also a tuning element 846 disposed across the inductive element 840, i.e., the antenna.
  • the transponder 67 has associated therewith a separate receive antenna or inductive element 850 disposed between node 813 and a node 852.
  • Node 852 is capacitively coupled to a receive node 854 with a coupling capacitor 856.
  • a receiver 858 is provided for receiving the information transmitted thereto and providing on the output thereof data on a data line 860.
  • the receiver 858 is operable to receive the RF signal, demodulate the data therefrom, and provide digital data on the output 860.
  • a transmitter 862 External to the human body and the transponder 67 is a transmitter 862 which is operable to impress a signal across an external inductive element 864.
  • the inductive element 864 basically provides the RF energy and is essentially tuned with a tuning element 866.
  • a corresponding tuning element 868 is provided on the transponder 67 and disposed across inductive element 850, the inductive element 850 acting as an antenna, as well as the inductive element 864.
  • the external location circuitry 61 may need to be inserted into the body proximate to the transponder 67 in order to couple the transmit/receive signals and power.
  • communication of power and data signals between the various transponders 67 may need to employ distinct time periods (i.e., time multiplexing) when communication occurs using a single common frequency, or discrimination circuits may need to be used where communication occurs simultaneously with the plurality of implanted transponders 67 having different oscillator frequencies.
  • FIGURE 9 there is illustrated a side view of an alternative embodiment utilizing additional circuitry or structure attached to a transponder for providing a local power source.
  • the transponder 67 requires a power-generating structure for storing a power supply voltage such that diodes must be provided for receiving and rectifying a large amount of power and charging up a power supply capacitor.
  • the transponder 67 could be configured to interface to an attached power supply system 900 comprising either a battery or a capacitor.
  • the local power supply system 900 is illustrated as disposed on a circuit board 903 defined by supporting structures 902 and 904.
  • the circuit board 903 contains electronics for interfacing the local power supply system 900 to the transponder 67.
  • FIGURE 10 there is illustrated a schematic block diagram of the transponder 67 having a battery as the local power supply system 900.
  • a battery 1001 is provided as a source of self-contained power and is connected across a capacitor 1000 to providing smoothing of any power output to the system power-consuming elements of the transponder 67. Power for all on-board components is obtained from the SYSTEM POWER output by providing sufficient charge to the capacitor 1000.
  • the capacitor 1000 could be formed on the surface of the transponder 67 or it could actually be part of the battery structure 1001.
  • the capacitance 1000 could actually be the capacitance of the battery 1001. Additional structure could be provided for powering the CPU 738 and the other circuitry on the transponder 67 from the battery 1001. As such, there would only be required a smaller inductive element 1002 and a capacitor 1004 to allow the receive/transmit block 742 to receive/transmit information from and to the remote exterior station 61.
  • the memory 739 and A/D 736 connect to the CPU 738, and optionally, to one another to facilitate conversion of the stored memory data prior to transmission from the transponder 67 to the monitor station 61.
  • FIGURE 11 there is illustrated a perspective view of the transponder 67, wherein the inductive element 704 (inductive element 1002 being similar thereto) is illustrated as being strips of conductive material wrapped around the outer region of the transponder 67.
  • the inductive element 704 is formed of a conductive strip wrapped many times around the transponder 67.
  • the length of inductive element 704 depends upon the receive characteristics that are required. As described hereinabove with reference to FIGURES 8A-8C, there could be multiple conductive strips, each associated with a receive function, a transmit function or a power function, or they could all share one single conductive element or strip.
  • interface balls (or partial balls called nodules) 1102 which can be made of non-reactive material, e.g., gold, to prevent degradation while in use in the body.
  • the interface nodules 1102 function as interface contacts with other balls, which other balls may be used to facilitate monitoring of quantitative data, or unique functions such as supplying only power or data buffering and storage.
  • FIGURE 12 there is illustrated a cross-sectional diagram of the semiconductor surface of the transponder 67 illustrating the conductive strips forming the inductive element 704.
  • the conductive strips are referred to by reference numeral 1210 which are spaced above the surface of the integrated circuit of the transponder 67 by a predetermined distance, and separated therefrom by a layer of silicon dioxide.
  • a passivation layer 1211 is then disposed over the upper surface of the conductive strips 1210.
  • the conductive strips 1210 can be fabricated from polycrystalline silicon but, it would be preferable to form them from the upper metal layer to result in a higher conductivity strip. This will allow the strips 1210 to be narrower and separated from each other by a larger distance. This separation would reduce the amount of capacitance therebetween.
  • the diode structure 1213 is formed of an N-well implant region 197 into which a P- well implant region 1216 is disposed, and an N-well implant region 1218 disposed within the P- well implant region 1216.
  • This forms a PN diode where one end of the conductive strips 1210, a conductive connection 1220, is connected to the P-well 1216 implant region, and a conductive layer 1222 is connected at one end to the N-well implant region 1218.
  • This conductive layer or strip 1222 extends outward to other circuitry on the integrated circuit and can actually form the capacitor. Since it needs to go to a capacitor directly, a lower plate 1224 formed of a layer of polycrystalline silicon or metal in a double-metal process, could be provided separated therefrom by a layer of oxide.
  • the device of the disclosed embodiment provides an almost microscopic spherical integrated circuit transponder or ball that can be imbedded in pills (medication in pill, capsule, or any other ingested form), and other medical items, to provide a method of positive identification.
  • the ball contains specific information in each pill such as the type of medication, its authenticity, dosage, manufacturer, lot number, date of manufacture, and date of expiration. Because of its size and its biologically inert properties, the ball is undigested and unaffected by the acid environment of the stomach. A small antenna on the ball allows it to send and receive radio frequency signals (RF transponder). The ball is eliminated from the body with normal bowel movements.
  • RF transponder radio frequency signals
  • the cost of the disclosed ball transducer 67 is sufficiently low and affordable to allow its inclusion in the smallest unit of medication. Simple RF sensing devices will be used to interrogate the transponder 67 within the pill and identify it beyond a level currently available with any existing system. It can be appreciated that pills for animals can be coded similarly to provide the same benefits. It would also provide a robust method of identifying which medications are for human or for veterinary use.
  • the positive, discrete identification of commercially manufactured medications at the single dosage level will improve many pharmaceutical activities including inventory control, distribution, prescription filling and the actual dispensing of medications to the patient. It will also have a major impact on medical practice by permitting health care workers to identify positively which medications the patient has taken and how many pills remain within the patient's body. This information can be obtained from patients who are not able to provide a medication history on their own (e.g. forgetful, memory-impaired, or unconscious patients). The radio-frequency signal from each pill would also provide some general information about its location within the gastrointestinal tract, from the esophagus through the colon.
  • the transponder 67 may be used to tag any medical product or device.
  • the transponder may be affixed or otherwise attached to a surgical sponge.
  • the transponder 67 would contain data to identify the sponge.
  • the patient's body at the site of the surgery would be scanned with a monitoring unit. If a sponge ball transponder 67 were to respond, the sponge could be located and removed.
  • Other medical items, such as surgical instruments, may be similarly tagged with the ball transponder 67.
  • the instruments could be scanned before surgery to generate an inventory. At the conclusion of surgery, the surgical suite can be scanned to account positively for all items in the inventory.
  • the trash cans or trash bags can be scanned.
  • the scanning can also be done for billing purposes. Hospitals now use bar codes for billing supply items.
  • the ball tags would be incorporated into the medical items, so the items are intact and can be scanned even after the package has been opened and discarded. Because the ball ID tags are small and inexpensive, they can be inserted into or attached to virtually every medical item or any other product.

Abstract

L'invention concerne une étiquette électronique qui permet d'identifier un produit médical. Un transpondeur passif miniature (15) comprend une bobine de puissance (21) pour raccorder le courant dans le transpondeur passif, un régulateur de puissance (23) pour réguler la puissance relativement à tous les circuits internes, une mémoire (25) contenant des données d'identification du produit médical, un oscillateur accordé par tension (OAT) (27) pour convertir les données stockées en un signal pouvant être mélangé, par un circuit mélangeur (31), avec un signal d'un oscillateur RF (29), et un amplificateur (33) pour amplifier le signal mélangé avant sa transmission, via une antenne (35), à un système de surveillance externe (17). La puissance générée par un générateur de champ (19) du système de surveillance (17) est couplée dans la bobine de puissance (21) du transpondeur (15) pour permettre la réception des données en mémoire par un récepteur RF (37) du système de surveillance (17). Le récepteur RF (37) est raccordé à une UCT (39) pour faciliter la démodulation du signal RF reçu en vue d'obtenir les données en mémoire du transpondeur (15). Les données peuvent ensuite être présentées à un opérateur sur un écran (41).
PCT/US1999/028095 1998-11-25 1999-11-24 Procede et systeme d'identification de produits medicaux WO2000033246A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU18328/00A AU1832800A (en) 1998-11-25 1999-11-24 Method of and system for identifying medical products

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11003598P 1998-11-25 1998-11-25
US60/110,035 1998-11-25

Publications (1)

Publication Number Publication Date
WO2000033246A1 true WO2000033246A1 (fr) 2000-06-08

Family

ID=22330892

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/028095 WO2000033246A1 (fr) 1998-11-25 1999-11-24 Procede et systeme d'identification de produits medicaux

Country Status (2)

Country Link
AU (1) AU1832800A (fr)
WO (1) WO2000033246A1 (fr)

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097730A2 (fr) * 2000-06-20 2001-12-27 Levin Bruce H Suivi d'instruments chirurgicaux a circuits integres
WO2002095675A1 (fr) * 2001-05-21 2002-11-28 Scott Laboratories, Inc. Etiquette d'identification rf pour receptacle medical
WO2004008387A1 (fr) * 2002-07-15 2004-01-22 Battelle Memorial Institute Systeme de reperage de dispositifs medicaux
EP1410767A1 (fr) * 2002-10-16 2004-04-21 Promepla Sam Dispositif à usage unique de transmissions d'informations, utilisé dans les domaines médicaux et chirurgicaux
WO2004111917A1 (fr) * 2003-06-18 2004-12-23 Siemens Aktiengesellschaft Dispositif d'identification pour accessoires medicaux et patients
CN100463704C (zh) * 2001-09-24 2009-02-25 斯科特实验室公司 集成药物输送系统
WO2010114576A1 (fr) * 2009-03-30 2010-10-07 Igt Jeton de pari intelligent et techniques pour le pistage de jeton de pari
US8277314B2 (en) 2006-11-10 2012-10-02 Igt Flat rate wager-based game play techniques for casino table game environments
JP2014507922A (ja) * 2010-12-29 2014-03-27 プロテウス デジタル ヘルス， インコーポレイテッド 集積回路のための無線エネルギー源
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8888005B2 (en) 2013-04-12 2014-11-18 David Prokop Uniquely identifiable drug dosage form units
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9149577B2 (en) 2008-12-15 2015-10-06 Proteus Digital Health, Inc. Body-associated receiver and method
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9597010B2 (en) 2005-04-28 2017-03-21 Proteus Digital Health, Inc. Communication system using an implantable device
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019958A1 (fr) * 1995-11-30 1997-06-05 Wlodek Mandecki Criblage des drogues a partir de bibliotheques chimiques combinatoires au moyen de transpondeurs
US5650596A (en) * 1994-08-05 1997-07-22 Surgical Resources, L.L.C. Automatic surgical sponge counter and blood loss determination system
US5725578A (en) * 1992-08-24 1998-03-10 Lipomatrix Incoporated Temporary implant with transponder and methods for locating and indentifying
US5732401A (en) * 1996-03-29 1998-03-24 Intellitecs International Ltd. Activity based cost tracking systems
WO1998025090A1 (fr) * 1996-12-04 1998-06-11 Ball Semiconductor Inc. Circuit integre a semi-conducteur et en forme de sphere
US5792048A (en) * 1996-09-03 1998-08-11 Schaefer; Guenter Indentification pill with integrated microchip: smartpill, smartpill with integrated microchip and microprocessor for medical analyses and a smartpill, smartbox, smartplague, smartbadge or smartplate for luggage control on commercial airliners

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725578A (en) * 1992-08-24 1998-03-10 Lipomatrix Incoporated Temporary implant with transponder and methods for locating and indentifying
US5650596A (en) * 1994-08-05 1997-07-22 Surgical Resources, L.L.C. Automatic surgical sponge counter and blood loss determination system
WO1997019958A1 (fr) * 1995-11-30 1997-06-05 Wlodek Mandecki Criblage des drogues a partir de bibliotheques chimiques combinatoires au moyen de transpondeurs
US5732401A (en) * 1996-03-29 1998-03-24 Intellitecs International Ltd. Activity based cost tracking systems
US5792048A (en) * 1996-09-03 1998-08-11 Schaefer; Guenter Indentification pill with integrated microchip: smartpill, smartpill with integrated microchip and microprocessor for medical analyses and a smartpill, smartbox, smartplague, smartbadge or smartplate for luggage control on commercial airliners
WO1998025090A1 (fr) * 1996-12-04 1998-06-11 Ball Semiconductor Inc. Circuit integre a semi-conducteur et en forme de sphere

Cited By (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001097730A3 (fr) * 2000-06-20 2002-06-13 Bruce H Levin Suivi d'instruments chirurgicaux a circuits integres
WO2001097730A2 (fr) * 2000-06-20 2001-12-27 Levin Bruce H Suivi d'instruments chirurgicaux a circuits integres
WO2002095675A1 (fr) * 2001-05-21 2002-11-28 Scott Laboratories, Inc. Etiquette d'identification rf pour receptacle medical
AU2009238236B2 (en) * 2001-05-21 2011-06-02 Scott Laboratories, Inc. Smart supplies, components and capital equipment
AU2008200356B2 (en) * 2001-05-21 2009-08-13 Scott Laboratories, Inc. Smart supplies, components and capital equipment
US7559483B2 (en) 2001-05-21 2009-07-14 Scott Laboratories, Inc. Smart supplies, components and capital equipment
JP2005514965A (ja) * 2001-05-21 2005-05-26 スコット・ラボラトリーズ・インコーポレイテッド 医療容器のためのｒｆ−ｉｄラベル
US7299981B2 (en) 2001-05-21 2007-11-27 Scott Laboratories, Inc. Smart supplies, components and capital equipment
CN100359530C (zh) * 2001-05-21 2008-01-02 斯科特实验室公司 医用容器的rf-id标签
CN100463704C (zh) * 2001-09-24 2009-02-25 斯科特实验室公司 集成药物输送系统
WO2004008387A1 (fr) * 2002-07-15 2004-01-22 Battelle Memorial Institute Systeme de reperage de dispositifs medicaux
FR2845888A1 (fr) * 2002-10-16 2004-04-23 Promepla Sam Dispositif a usage unique de transmissions d'informations, utilise dans les domaines medicaux et chirurgicaux
EP1410767A1 (fr) * 2002-10-16 2004-04-21 Promepla Sam Dispositif à usage unique de transmissions d'informations, utilisé dans les domaines médicaux et chirurgicaux
WO2004111917A1 (fr) * 2003-06-18 2004-12-23 Siemens Aktiengesellschaft Dispositif d'identification pour accessoires medicaux et patients
US8847766B2 (en) 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US11476952B2 (en) 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9597010B2 (en) 2005-04-28 2017-03-21 Proteus Digital Health, Inc. Communication system using an implantable device
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US10610128B2 (en) 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US9119554B2 (en) 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US9681842B2 (en) 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US8277314B2 (en) 2006-11-10 2012-10-02 Igt Flat rate wager-based game play techniques for casino table game environments
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9149577B2 (en) 2008-12-15 2015-10-06 Proteus Digital Health, Inc. Body-associated receiver and method
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
WO2010114576A1 (fr) * 2009-03-30 2010-10-07 Igt Jeton de pari intelligent et techniques pour le pistage de jeton de pari
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
JP2014507922A (ja) * 2010-12-29 2014-03-27 プロテウス デジタル ヘルス， インコーポレイテッド 集積回路のための無線エネルギー源
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US11741771B2 (en) 2013-03-15 2023-08-29 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US8888005B2 (en) 2013-04-12 2014-11-18 David Prokop Uniquely identifiable drug dosage form units
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US11102038B2 (en) 2013-09-20 2021-08-24 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10097388B2 (en) 2013-09-20 2018-10-09 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10498572B2 (en) 2013-09-20 2019-12-03 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9787511B2 (en) 2013-09-20 2017-10-10 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US11950615B2 (en) 2014-01-21 2024-04-09 Otsuka Pharmaceutical Co., Ltd. Masticable ingestible product and communication system therefor
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers

Also Published As

Publication number Publication date
AU1832800A (en) 2000-06-19

Similar Documents

Publication Publication Date Title
WO2000033246A1 (fr) Procede et systeme d'identification de produits medicaux
US6366206B1 (en) Method and apparatus for attaching tags to medical and non-medical devices
US10765360B2 (en) Electronic medication compliance monitoring system and associated methods
US9060708B2 (en) Multi-mode communication ingestible event markers and systems, and methods of using the same
DK2425824T3 (en) Pharmaceutical preparation containing oxycodone and naloxone
US10292642B2 (en) Electronic medication compliance monitoring system and associated methods
US20200254268A1 (en) Transbody communication systems employing communication channels
CN102791189A (zh) 药物方案顺从性监测系统和方法
US20200143926A1 (en) Electronic compliance system and associated methods
US20140309505A1 (en) Electronic medication compliance monitoring system and associated methods
WO2000032095A1 (fr) Thermometre interne
US20130181048A1 (en) Method and apparatus for storing and tracking information relating to a medical implant device
US20200229758A1 (en) Ingestible electronic medical device
CA2909033C (fr) Systeme electronique de surveillance de la conformite de la medication et methodes associees
AU2015243053A1 (en) Electronic medication compliance monitoring system and associated methods

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 18328

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase